BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Array BioPharma, Inc. to Present Clinical Data at the 2012 American Society of Hematology Meeting on ARRY-520, a KSP Inhibitor, and ARRY-614, a Dual p38/Tie2 Inhibitor

  November 5, 2012

   · 

  10 min read
• Drug Development

  Novel Apolipoprotein A-I Therapy, CSL Limited112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show

  November 5, 2012

   · 

  4 min read
• Genetown

  Celldex Therapeutics, Inc. Announces Upcoming Data Presentations at the Society for Neuro-Oncology 17th Annual Scientific Meeting and Education Day

  November 5, 2012

   · 

  1 min read
• Drug Development

  FibroGen, Inc. Announces Results Showing That FG-4592, An Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI), Corrects Anemia Without Intravenous Iron Supplementation in Incident Dialysis Patients

  November 5, 2012

   · 

  1 min read
• Business

  BioLineRx Ltd. to Report Third Quarter 2012 Results on November 14, 2012

  November 5, 2012

   · 

  1 min read
• Business

  TauRx Therapeutics Selects BioClinica, Inc. for eClinical and Imaging Solutions

  November 5, 2012

   · 

  1 min read
• China Biologic Products to Report Third Quarter 2012 Financial Results

  November 5, 2012

   · 

  1 min read
• Pharm Country

  FDA Mini-Sentinel Assessment Reinforces Safety Data of Pradaxa® (Dabigatran Etexilate Mesylate)

  November 5, 2012

   · 

  6 min read
• Pharm Country

  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Keryx Biopharmaceuticals to Contact the Firm

  November 5, 2012

   · 

  1 min read
• Biotech Beach

  Regulus Therapeutics, Inc. Presents New Preclinical Data on miR-21 at Kidney Week 2012

  November 5, 2012

   · 

  3 min read